Brain Tumors clinical trials

Explore recruiting brain tumors clinical trials.

Recruiting brain tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Brain Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pharmacokinetics of antibiotics in cerebrospinal fluid of children with malignant brain tumors – a pilot study

Austria

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

TARLATEM : Combination of TARLAtamab and TEMozolomide in patients with central nervous system tumors. A multicenter, open-label Phase I/II trial aiming to assess the safety and clinical activity of Tarlatamab in combination with metronomic Temozolomide in adolescents and adults’ patients with high grade brain tumors

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Clinical safety study on 5-Aminolevulinic acid (5-ALA) in children and adolescents with brain tumors (5-ALA in children and adolescents)

Germany, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Imaging Perfusion Restrictions from Extracellular Solid Stress - An open-label losartan study (ImPRESS)

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

INTRATUMORAL DNX-2401 ADMINISTRATION FOR RECURRENT AND REFRACTORY HIGH GRADE BRAIN TUMORS IN PEDIATRIC AND YOUNG ADULT PATIENTS

Netherlands, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Study Investigating Tucatinib and Osimertinib Pharmacokinetics in Primary and Metastatic Brain Tumors: the STICK trial

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Brain Tumors trials by city

Brain Tumors in Toronto Brain Tumors in Vancouver Brain Tumors in Montreal Brain Tumors in Calgary Brain Tumors in Edmonton Brain Tumors in Ottawa Brain Tumors in Winnipeg Brain Tumors in Quebec City Brain Tumors in Hamilton Brain Tumors in Kitchener Brain Tumors in London Brain Tumors in Halifax Brain Tumors in New York Brain Tumors in Los Angeles Brain Tumors in Chicago Brain Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease